NASDAQ

CRISPR Therapeutics AG - Common Shares (CRSP)

♥ 617 Thanks from members

Live price chart, market sentiment, and community perspectives for CRISPR Therapeutics AG - Common Shares (NASDAQ: CRSP).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Emmanuelle CharpentierFounder: Rodolphe BarrangouFounder: Jennifer DoudnaLeadership: Samarth Kulkarni (CEO)Leadership: Magdalena MaloHolder: ARK Investment ManagementHolder: The Vanguard GroupHolder: FMR, LLCCasgevyCRISPR/Cas9 gene editing pipeline#CRSP stock#CRISPR Therapeutics#gene editing biotech#NASDAQ CRSP#genetic medicine